Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells
Viral Immunology · 2024
DOI: 10.1089/vim.2023.0118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2024. Verfasst von Chung-Chun Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Translational Cell Therapy Center, China Medical University Hospital, Taichung City, Taiwan. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms, Immediate-Early Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Research, Translational Cell Therapy Center, China Medical University Hospital, Taichung City, Taiwan.
- National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
ORCID-Profile: Chung-Chun Wu
Zitieren
APA
Wu, C. C., Chen, M. S., Lee, T. Y., Huang, T. S., Cho, D. Y., & Chen, J. Y. (2024). Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells. Viral Immunology. https://doi.org/10.1089/vim.2023.0118
Vancouver
Wu CC, Chen MS, Lee TY, Huang TS, Cho DY, Chen JY. Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells. Viral Immunology. 2024. doi:10.1089/vim.2023.0118
BibTeX
@article{Wu2024,
author = {Wu, Chung-Chun and Chen, Mei-Shu and Lee, Ting-Ying and Huang, Tze-Sing and Cho, Der-Yang and Chen, Jen-Yang},
title = {Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells},
journal = {Viral Immunology},
year = {2024},
doi = {10.1089/vim.2023.0118}
}
EUVIMED